BLUE
bluebird bio
BLUE
BLUE
Delisted
BLUE was delisted on the 30th of May, 2025.
123 hedge funds and large institutions have $845M invested in bluebird bio in 2014 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 54 increasing their positions, 20 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
18% more funds holding
Funds holding: 104 → 123 (+19)
14% more capital invested
Capital invested by funds: $742M → $845M (+$103M)
Holders
123
Holding in Top 10
3
Calls
$19M
Puts
$6.3M
Top Buyers
| 1 | +$38.3M | |
| 2 | +$21.9M | |
| 3 | +$17.9M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$17.7M |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$13.6M |
Top Sellers
| 1 | -$43.1M | |
| 2 | -$25.3M | |
| 3 | -$6.9M | |
| 4 |
PC
PointState Capital
New York
|
-$5.2M |
| 5 |
Goldman Sachs
New York
|
-$2.24M |